← All trials
NCT00654576
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2005
- Primary completion
- Dec 1, 2007
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 1400
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Central South UniversityLead sponsor
- Sichuan UniversityCollaborator
- Capital Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Jiangxi Mental HospitalCollaborator
- Hunan Mental HospitalCollaborator
- Henan Medical UniversityCollaborator
- Chongqing Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.